Abstract:Background Mutations within the genes PRKN and PINK1 are the leading cause of early onset autosomal recessive Parkinson's disease (PD). However, the genetic cause of most early-onset PD (EOPD) cases still remains unresolved. Long-read sequencing has successfully identified many pathogenic structural variants that cause disease, but this technology has not been widely applied to PD. We recently identified the genetic cause of EOPD in a pair of monozygotic twins by uncovering a complex structural variant that spans over 7 Mb, utilizing Oxford Nanopore Technologies (ONT) long-read sequencing. In this study, we aimed to expand on this and assess whether a second variant could be detected with ONT long-read sequencing in other unresolved EOPD cases reported to carry one heterozygous variant in PRKN or PINK1. Methods ONT long-read sequencing was performed on patients with one reported PRKN/PINK1 pathogenic variant. EOPD patients with an age at onset younger than 50 were included in this study. As a positive control, we also included EOPD patients who had already been identified to carry two known PRKN pathogenic variants. Initial genetic testing was performed using either short-read targeted panel sequencing for single nucleotide variants and multiplex ligation-dependent probe amplification (MLPA) for copy number variants. Results 48 patients were included in this study (PRKN 'one-variant' n = 24, PINK1 'one-variant' n = 12, PRKN 'two-variants' n = 12). Using ONT long-read sequencing, we detected a second pathogenic variant in six PRKN 'one-variant' patients (26%, 6/23) but none in the PINK1 'one-variant' patients (0%, 0/12). Long-read sequencing identified one case with a complex inversion, two instances of structural variant overlap, and three cases of duplication. In addition, in the positive control PRKN 'two-variants' group, we were able to identify both pathogenic variants in PRKN in all the patients (100%, 12/12). Conclusions This data highlights that ONT long-read sequencing is a powerful tool to identify a pathogenic structural variant at the PRKN locus that is often missed by conventional methods. Therefore, for cases where conventional methods fail to detect a second variant for EOPD, long-read sequencing should be considered as an alternative and complementary approach.

Co-occurrence of PRKN and SYNJ1 variants in Early-Onset Parkinson's disease

Novel Compound Heterozygous of PARKIN Causes Early-Onset Parkinson's Disease

Phenotypic Overlap among Paroxysmal Dyskinesia Subtypes: Lesson from a Family with PRRT2 Gene Mutation.

Gene-based Burden Analysis of Damaging Private Variants in PRKN, PARK7 and PINK1 in Parkinson's Disease Cohorts of European Descent

PRKN-linked familial Parkinson's disease: cellular and molecular mechanisms of disease-linked variants

Clinical and Functional Evidence for the Pathogenicity of the LRRK2 P.arg1067gln Variant

A heterozygous de novo PSEN1 mutation in a patient with early-onset parkinsonism

Genotype–phenotype correlation in PRKN-associated Parkinson’s disease

Are rare heterozygous SYNJ1 variants associated with Parkinson's disease?

A Novel Homozygous SYNJ1 Mutation in Two Siblings with Typical Parkinson's Disease.

Upregulated ECM genes and increased synaptic activity in Parkinson's human DA neurons with PINK1/ PRKN mutations

Genetic Analysis of ATP13A2, PLA2G6 and FBXO7 in a Cohort of Chinese Patients with Early-Onset Parkinson's Disease.

Parkin Mutation Decreases Neurite Complexity and Maturation in Neurons Derived from Human Fibroblasts

Are rare heterozygous variants associated with Parkinson’s disease?

Haplotype Analysis on the Relationship of the DNAJC6 Gene with Early-Onset Parkinson's Disease Risk in a Chinese Population.

Analysis of Rare Variants of Autosomal‐dominant Genes in a Chinese Population with Sporadic Parkinson’s Disease

The Utility of Long-Read Sequencing in Diagnosing Genetic Autosomal Recessive Parkinson's Disease: a genetic screening study

Identification of SYNJ1 in a Complex Case of Juvenile Parkinsonism Using a Multiomics Approach

Mutation Analysis of DJ-1 in Patients with Early-Onset Parkinson's Disease and Relationship Between the G.168_185del Polymorphism and Parkinson's Disease

Novel compound heterozygous of PARKIN causes early-onset Parkinson’s disease

α‐Synuclein Pathology in PRKN‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification Assay